Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dolby Laboratories, Inc.DLB · Entity 2518 | VP, CAO and Corp. Controller | August 25, 2026 | August 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dolby Laboratories, Inc.
Report date August 25, 2026 · Filed August 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 34,453 |
Reported balance
After 2026-08-25 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-25 · Sale · Disposed 1,183 · Balance 34,453 F1: Shares held following the reported transaction includes 19,303 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held following the reported transaction includes 19,303 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2026 Filed Aug 28, 2026 00:15 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,183 | $65.28 | $77,223.05 |
DisclosureSEC source: 0001193125-26-371803 · ownership.xml · nonDerivative · entry 1 Nicholson Ryan · CIK 0001767009 · VP, CAO and Corp. Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,453 F1 · balance_after: Shares held following the reported transaction includes 19,303 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| August 10, 2026 Filed Aug 12, 2026 20:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,348 | $62.04 | $83,629.92 |
DisclosureSEC source: 0001193125-26-346962 · ownership.xml · nonDerivative · entry 1 Nicholson Ryan · CIK 0001767009 · VP, CAO and Corp. Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,636 F1 · balance_after: Shares held following the reported transaction includes 19,303 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| August 04, 2026 Filed Aug 6, 2026 21:28 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 357 | $60.63 | $21,644.91 |
DisclosureSEC source: 0001193125-26-338476 · ownership.xml · nonDerivative · entry 1 Nicholson Ryan · CIK 0001767009 · VP, CAO and Corp. Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,984 F1 · balance_after: Shares held following the reported transaction includes 19,303 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 385 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 22:57 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,667 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001193125-26-055254 · ownership.xml · derivative · entry 3 Nicholson Ryan · CIK 0001767009 · VP, CAO and Corp. Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,667 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 2,667 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 22:57 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,667 | $66.38 | $177,022.66 |
DisclosureSEC source: 0001193125-26-055254 · ownership.xml · nonDerivative · entry 2 Nicholson Ryan · CIK 0001767009 · VP, CAO and Corp. Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,956 F2 · price: The shares were sold in multiple transactions at prices ranging from $66.37 to $66.39, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 19,303 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 22:57 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 2,667 | $45.50 | $121,348.50 |
DisclosureSEC source: 0001193125-26-055254 · ownership.xml · nonDerivative · entry 1 Nicholson Ryan · CIK 0001767009 · VP, CAO and Corp. Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 19,303 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 02:46 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 649 | $66.62 | $43,236.38 |
DisclosureSEC source: 0001193125-25-323440 · ownership.xml · nonDerivative · entry 3 Nicholson Ryan · CIK 0001767009 · VP, CAO and Corp. Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,956 F4 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F6 · balance_after: Shares held following the reported transactions include 19,303 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2025 Filed Dec 18, 2025 02:46 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,535 | $67.54 | $103,673.90 |
DisclosureSEC source: 0001193125-25-323440 · ownership.xml · nonDerivative · entry 2 Nicholson Ryan · CIK 0001767009 · VP, CAO and Corp. Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,605 F4 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F5 · balance_after: Shares held following the reported transactions include 21,135 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2025 Filed Dec 18, 2025 02:46 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 9,032 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-323440 · ownership.xml · nonDerivative · entry 1 Nicholson Ryan · CIK 0001767009 · VP, CAO and Corp. Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,140 F1 · acquired: Award represents a total of 9,032 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2025. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 25,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F3 · balance_after: Shares include 313 and 37 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025 and November 17, 2025, respectively. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 00:51 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $33.15 | $0.00 |
DisclosureSEC source: 0000950170-25-015672 · ownership.xml · derivative · entry 3 Nicholson Ryan · CIK 0001767009 · VP, CAO and Corp. Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 7,000 shares Expires 2025-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 7,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 00:51 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 7,000 | $84.07 | $588,480.20 |
DisclosureSEC source: 0000950170-25-015672 · ownership.xml · nonDerivative · entry 2 Nicholson Ryan · CIK 0001767009 · VP, CAO and Corp. Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,758 F2 · price: The shares were sold in multiple transactions at prices ranging from $84.02 to $84.10, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 16,438 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 00:51 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 7,000 | $33.15 | $232,050.00 |
DisclosureSEC source: 0000950170-25-015672 · ownership.xml · nonDerivative · entry 1 Nicholson Ryan · CIK 0001767009 · VP, CAO and Corp. Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,758 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 16,438 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2024 Filed Dec 19, 2024 02:33 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,934 | $79.18 | $153,134.12 |
DisclosureSEC source: 0000950170-24-138174 · ownership.xml · nonDerivative · entry 2 Nicholson Ryan · CIK 0001767009 · VP, CAO and Corp. Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,758 F3 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F4 · balance_after: Shares held following the reported transactions include 16,438 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2024 Filed Dec 19, 2024 02:33 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 7,328 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-138174 · ownership.xml · nonDerivative · entry 1 Nicholson Ryan · CIK 0001767009 · VP, CAO and Corp. Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,692 F1 · acquired: Award represents a total of 7,328 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 16, 2024. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 21,898 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 21:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,500 | $0.00 Strike: $31.73 | $0.00 |
DisclosureSEC source: 0000950170-24-131570 · ownership.xml · derivative · entry 3 Nicholson Ryan · CIK 0001767009 · VP, CAO and Corp. Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 10,500 shares Expires 2025-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted for a total of 10,500 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date. Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 21:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 10,500 | $80.18 | $841,907.85 |
DisclosureSEC source: 0000950170-24-131570 · ownership.xml · nonDerivative · entry 2 Nicholson Ryan · CIK 0001767009 · VP, CAO and Corp. Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,364 F3 · price: The shares were sold in multiple transactions at prices ranging from $80.12 to $80.35, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 14,570 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 21:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 10,500 | $31.73 | $333,165.00 |
DisclosureSEC source: 0000950170-24-131570 · ownership.xml · nonDerivative · entry 1 Nicholson Ryan · CIK 0001767009 · VP, CAO and Corp. Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,864 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 14,570 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 257 shares and 29 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2024 and November 15, 2024, respectively. Read SEC document |
| December 16, 2023 Filed Dec 20, 2023 00:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 195 | $87.49 | $17,060.55 |
DisclosureSEC source: 0001209191-23-059256 · doc4.xml · nonDerivative · entry 3 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,078 F4 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F6 · balance_after: Shares held following the reported transactions include 14,570 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2023 Filed Dec 20, 2023 00:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,350 | $88.60 | $119,610.00 |
DisclosureSEC source: 0001209191-23-059256 · doc4.xml · nonDerivative · entry 2 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,273 F4 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F5 · balance_after: Shares held following the reported transactions include 15,133 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2023 Filed Dec 20, 2023 00:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 6,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-059256 · doc4.xml · nonDerivative · entry 1 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,623 F1 · acquired: Award represents a total of 6,253 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2023. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 19,030 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F3 · balance_after: Shares include 293 shares and 64 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2023 and November 15, 2023, respectively. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 23:55 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,600 | $0.00 Strike: $37.35 | $0.00 |
DisclosureSEC source: 0001209191-23-007893 · doc4.xml · derivative · entry 6 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 3,600 shares Expires 2023-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was originally granted for a total of 3,600 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 23:55 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,025 | $0.00 Strike: $42.98 | $0.00 |
DisclosureSEC source: 0001209191-23-007893 · doc4.xml · derivative · entry 5 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 3,025 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was originally granted for a total of 3,025 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 23:55 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 354 | $84.56 | $29,932.89 |
DisclosureSEC source: 0001209191-23-007893 · doc4.xml · nonDerivative · entry 4 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,013 F3 · price: This transaction was executed in multiple trades at prices ranging from $84.55 to $84.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 12,777 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 23:55 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 6,625 | $84.56 | $560,188.80 |
DisclosureSEC source: 0001209191-23-007893 · doc4.xml · nonDerivative · entry 3 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,367 F2 · price: This transaction was executed in multiple trades at prices ranging from $84.50 to $84.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 12,777 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 23:55 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 3,600 | $37.35 | $134,460.00 |
DisclosureSEC source: 0001209191-23-007893 · doc4.xml · nonDerivative · entry 2 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,992 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 12,777 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 23:55 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 3,025 | $42.98 | $130,014.50 |
DisclosureSEC source: 0001209191-23-007893 · doc4.xml · nonDerivative · entry 1 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 12,777 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 19, 2022 Filed Dec 20, 2022 02:41 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 217 | $70.80 | $15,363.60 |
DisclosureSEC source: 0001209191-22-062077 · doc4.xml · nonDerivative · entry 4 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,367 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F7 · balance_after: Shares held following the reported transactions include 12,777 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 02:41 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 195 | $71.07 | $13,858.65 |
DisclosureSEC source: 0001209191-22-062077 · doc4.xml · nonDerivative · entry 3 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,584 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F6 · balance_after: Shares held following the reported transactions include 13,402 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2022 Filed Dec 20, 2022 02:41 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 6,589 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-062077 · doc4.xml · nonDerivative · entry 2 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,779 F4 · acquired: Award represents a total of 6,589 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2022. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F5 · balance_after: Shares held following the reported transactions include 13,965 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2022 Filed Dec 20, 2022 02:41 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 780 | $73.17 | $57,072.60 |
DisclosureSEC source: 0001209191-22-062077 · doc4.xml · nonDerivative · entry 1 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,190 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 7,376 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F3 · balance_after: Shares include 261 shares and 24 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2022 and November 15, 2022, respectively. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 01:39 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 217 | $92.00 | $19,964.00 |
DisclosureSEC source: 0001209191-21-070704 · doc4.xml · nonDerivative · entry 1 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,685 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 9,626 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 02:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 195 | $91.80 | $17,901.00 |
DisclosureSEC source: 0001209191-21-070101 · doc4.xml · nonDerivative · entry 3 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,902 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F6 · balance_after: Shares held following the reported transactions include 10,251 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 02:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070101 · doc4.xml · nonDerivative · entry 2 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,097 F4 · acquired: Award represents a total of 4,500 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2021. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F5 · balance_after: Shares held following the reported transactions include 10,813 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 02:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 661 | $90.55 | $59,853.55 |
DisclosureSEC source: 0001209191-21-070101 · doc4.xml · nonDerivative · entry 1 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,597 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 6,313 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F3 · balance_after: Shares include 72 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2021. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 22:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,900 | $0.00 Strike: $30.49 | $0.00 |
DisclosureSEC source: 0001209191-21-052012 · doc4.xml · derivative · entry 4 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,900 shares Expires 2022-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 4,800 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 21, 2012, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 22:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,900 | $101.06 | $293,065.59 |
DisclosureSEC source: 0001209191-21-052012 · doc4.xml · nonDerivative · entry 3 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,186 F4 · price: The shares were sold in multiple transactions at prices ranging from $101.055 to $101.061, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 8,220 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 22:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 2,900 | $30.49 | $88,421.00 |
DisclosureSEC source: 0001209191-21-052012 · doc4.xml · nonDerivative · entry 2 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Shares held following the reported transactions include 8,220 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 22:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 364 | $101.03 | $36,776.63 |
DisclosureSEC source: 0001209191-21-052012 · doc4.xml · nonDerivative · entry 1 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,186 F1 · price: This transaction was executed in multiple trades at prices ranging from $101.023 to $101.045. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 8,220 restricted stock units, which are subject to forfeiture until they vest. F3 · balance_after: Shares include 327 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2021. Read SEC document |
| February 03, 2021 Filed Feb 4, 2021 23:44 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,237 | $91.01 | $203,582.66 |
DisclosureSEC source: 0001209191-21-007880 · doc4.xml · nonDerivative · entry 1 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,223 F1 · price: This transaction was executed in multiple trades at prices ranging from $90.95 to $91.02 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 8,220 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 17, 2020 Filed Dec 21, 2020 22:50 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 217 | $91.03 | $19,753.51 |
DisclosureSEC source: 0001209191-20-064693 · doc4.xml · nonDerivative · entry 1 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,460 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 8,220 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 00:25 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 195 | $92.08 | $17,955.60 |
DisclosureSEC source: 0001209191-20-064232 · doc4.xml · nonDerivative · entry 3 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,677 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F6 · balance_after: Shares held following the reported transactions include 8,845 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-064232 · doc4.xml · nonDerivative · entry 2 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,872 F4 · acquired: Award represents a total of 4,500 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2020. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F5 · balance_after: Shares held following the reported transactions include 9,407 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 444 | $90.86 | $40,341.84 |
DisclosureSEC source: 0001209191-20-064232 · doc4.xml · nonDerivative · entry 1 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,372 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 4,907 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F3 · balance_after: Shares include 27 shares acquired under the Issuer's Employee Stock Purchase Plan on November 16, 2020. Read SEC document |
| August 26, 2020 Filed Aug 27, 2020 22:04 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 395 | $0.00 Strike: $28.24 | $0.00 |
DisclosureSEC source: 0001209191-20-048562 · doc4.xml · derivative · entry 4 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 395 shares Expires 2021-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 1,113 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2011, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| August 26, 2020 Filed Aug 27, 2020 22:04 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 395 | $70.62 | $27,894.43 |
DisclosureSEC source: 0001209191-20-048562 · doc4.xml · nonDerivative · entry 3 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,789 F2 · balance_after: Shares held following the reported transactions include 6,188 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| August 26, 2020 Filed Aug 27, 2020 22:04 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 395 | $28.24 | $11,154.80 |
DisclosureSEC source: 0001209191-20-048562 · doc4.xml · nonDerivative · entry 2 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Shares held following the reported transactions include 6,188 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| August 26, 2020 Filed Aug 27, 2020 22:04 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 506 | $70.68 | $35,761.55 |
DisclosureSEC source: 0001209191-20-048562 · doc4.xml · nonDerivative · entry 1 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,789 F1 · balance_after: Shares include 364 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2020. F2 · balance_after: Shares held following the reported transactions include 6,188 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 11, 2020 Filed Feb 12, 2020 21:13 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,740 | $0.00 Strike: $25.00 | $0.00 |
DisclosureSEC source: 0001209191-20-008709 · doc4.xml · derivative · entry 4 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,740 shares Expires 2021-10-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 5,568 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of October 17, 2011, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 11, 2020 Filed Feb 12, 2020 21:13 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,180 | $71.59 | $84,479.74 |
DisclosureSEC source: 0001209191-20-008709 · doc4.xml · nonDerivative · entry 3 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,931 F2 · price: This transaction was executed in multiple trades at prices ranging from $71.58 to $71.61 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 6,188 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 11, 2020 Filed Feb 12, 2020 21:13 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,740 | $71.63 | $124,636.20 |
DisclosureSEC source: 0001209191-20-008709 · doc4.xml · nonDerivative · entry 2 Nicholson Ryan · CIK 0001767009 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,111 F1 · balance_after: Shares held following the reported transactions include 6,188 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.